Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

NCT01406431 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia
Hypertension

Interventions

DRUG: Pitavastatin, Valsartan
DRUG: Livalo® fixed combination drug

Sponsor

JW Pharmaceutical